Biochemical Mechanisms of New Molecular Entities (NMEs) Approved by United States FDA During 2001-2004: Mechanisms Leading to Optimal Efficacy and Safety

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|5|461-478

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.5, 2006-03, pp. : 461-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The US FDA approved 31 new molecular entities in 2004, the highest number in 5 years

By  

Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

New molecular entities (NMEs) were the main driver of increased spending on prescription drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 366, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Mechanisms Determining Opposed Functional States of Microglia

By  

Current Neuropharmacology, Vol. 1, Iss. 3, 2003-09 ,pp. : 245-265

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)

By Leneva I.   Glushkov R.   Gus’kova T.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 11, 2004-11 ,pp. : 590-596

Springer Publishing Company

Access to resources Recommend Favorite